{"nct_id":"NCT05181683","title":"COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2022-01-07","start_date_type":"ACTUAL","primary_completion_date":"2022-06-03","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}